Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
This study has been completed.
Study NCT00587964 Information provided by Memorial Sloan-Kettering Cancer Center
First Received: December 26, 2007 Last Updated: March 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brain Metastasis
Bladder Cancer
Breast Cancer
Cervical Cancer
Colon Cancer
HEENT Cancer
Lung Cancer
Melanoma
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Sarcoma
Testicular Cancer
Additional conditions recognized in this trial
Brain Neoplasms
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Neoplasm Metastasis
Pancreatic Neoplasms
Prostatic Neoplasms
Rectal Neoplasms
Testicular Neoplasms
Urinary Bladder Neoplasms
More general conditions related to this trial
Brain Diseases
Breast Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Male
Genital Neoplasms, Male
Gonadal Disorders
Intestinal Diseases
Intestinal Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neoplastic Processes
Nervous System Diseases
Nervous System Neoplasms
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pancreatic Diseases
Pathologic Processes
Prostatic Diseases
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Testicular Diseases
Thoracic Neoplasms
Urinary Bladder Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
Stereotactic Radiosurgery
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
Back to top of Main Content
